|
|
- 2019
Clinical value of an adenosine triphosphate-based chemotherapy response assay in resectable stage III colorectal cancerDOI: 10.4174/astr.2019.97.2.93 Keywords: Adenosine triphosphate, Antitumor drug screening assays, Colorectal neoplasms, FOLFOX regimen, adjuvant chemotherapy Abstract: ATP-based chemotherapy response assay (ATP-CRA) is a well-documented and validated technology that can individualize chemotherapy. This study was undertaken to assess the usefulness of ATP-CRA in advanced colorectal cancer (CRC) patients receiving adjuvant chemotherapy
|
